furosemide has been researched along with Cardiac Edema in 26 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 9.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
"This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 9.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
"In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 9.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
"The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 5.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
"Tolvaptan exerts diuretic effects and causes body weight loss at the low dose of 7." | 5.15 | Phase III clinical pharmacology study of tolvaptan. ( Hirayama, A; Hori, M; Inomata, T; Izumi, T; Matsuzaki, M, 2011) |
"This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 5.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
"In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 5.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
"The efficacy and tolerability of two combinations, namely 50 mg spironolactone + 20 mg furosemide (SF) or 50 mg spironolactone + 5 mg butizide (SB), were compared in a randomised intraindividual trial in 22 patients with congestive heart failure." | 5.05 | [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure]. ( Ehrlich, E; Mauersberger, H; Rangoonwala, B, 1985) |
"In the long-term therapy of congestive heart failure hydrochlorothiazide together with potassium-sparing amiloride is a pleasant and effective therapy for patients with normal renal function, but the risk of hypokalaemia must be kept in mind also when using this combination." | 2.65 | The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin. ( Huikko, M; Varjoranta, K; Viherkoski, M, 1981) |
" Torasemide also has a high bioavailability and is only slightly influenced by meals in humans." | 2.41 | [Torasemide (LUPRAC): a review of its pharmacological and clinical profile]. ( Kido, H; Ohtaki, Y, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (57.69) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 5 (19.23) | 29.6817 |
2010's | 4 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biegus, J | 1 |
Zymlinski, R | 1 |
Siwolowski, P | 1 |
Testani, J | 1 |
Szachniewicz, J | 1 |
Tycińska, A | 1 |
Banasiak, W | 1 |
Halpert, A | 1 |
Levin, H | 1 |
Ponikowski, P | 1 |
Parrinello, G | 1 |
Torres, D | 1 |
Paterna, S | 1 |
di Pasquale, P | 1 |
Licata, G | 1 |
Tabak'ian, EA | 1 |
Zaruba, AIu | 1 |
Miasnikov, RP | 1 |
Ataullakhanova, DM | 1 |
Kukharchuk, VV | 1 |
Matsuzaki, M | 2 |
Hori, M | 2 |
Izumi, T | 2 |
Asanoi, H | 1 |
Tsutamoto, T | 1 |
Inomata, T | 1 |
Hirayama, A | 1 |
Gheorghiade, M | 1 |
Niazi, I | 1 |
Ouyang, J | 1 |
Czerwiec, F | 1 |
Kambayashi, J | 1 |
Zampino, M | 1 |
Orlandi, C | 1 |
Rogers, HL | 1 |
Marshall, J | 1 |
Bock, J | 1 |
Dowling, TC | 1 |
Feller, E | 1 |
Robinson, S | 1 |
Gottlieb, SS | 1 |
Ghali, JK | 1 |
Vaitkevicius, P | 1 |
Magrini, F | 1 |
Niarchos, AP | 1 |
Davies, IB | 1 |
Lightman, SL | 1 |
Viherkoski, M | 1 |
Huikko, M | 1 |
Varjoranta, K | 1 |
Gabriel, R | 1 |
Baylor, P | 1 |
Furrer, J | 1 |
Hess, OM | 1 |
Kuhlmann, U | 1 |
Satz, N | 1 |
Siegenthaler, W | 1 |
Gabriel, S | 1 |
Ekelund, LG | 1 |
Orö, L | 1 |
Chomsky, DB | 1 |
Lang, CC | 1 |
Rayos, G | 1 |
Wilson, JR | 1 |
Kido, H | 1 |
Ohtaki, Y | 1 |
Marone, C | 1 |
Beretta-Piccoli, C | 1 |
Weidmann, P | 1 |
Lawson, DH | 2 |
Gray, JM | 2 |
Henry, DA | 1 |
Tillstone, WJ | 1 |
Apra, RM | 1 |
Corvalán, A | 1 |
Boddy, K | 1 |
Mahaffey, M | 1 |
Mills, E | 1 |
Murdoch, WR | 1 |
Auld, WH | 1 |
Ehrly, AM | 1 |
Kröger, N | 1 |
Szuba, J | 1 |
Frenzel, H | 1 |
Mauersberger, H | 1 |
Rangoonwala, B | 1 |
Ehrlich, E | 1 |
Pupita, F | 1 |
Campolucci, G | 1 |
Pulido, M | 1 |
Belogi, M | 1 |
Rotatori, P | 1 |
Ansuini, R | 1 |
Frausini, G | 1 |
Barone, A | 1 |
Gaggi, S | 1 |
Tojo, S | 1 |
Suzuki, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Role of Vasopressin Antagonism on Renal Sodium Handling[NCT03910231] | Phase 1 | 30 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for furosemide and Cardiac Edema
Article | Year |
---|---|
Refractory oedema.
Topics: Aminophylline; Bumetanide; Diuretics; Drug Therapy, Combination; Edema; Edema, Cardiac; Ethacrynic A | 1980 |
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hyp | 2001 |
10 trials available for furosemide and Cardiac Edema
Article | Year |
---|---|
Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
Topics: Acute Disease; Aged; Central Venous Pressure; Creatinine; Diuretics; Edema, Cardiac; Equipment and S | 2019 |
[Application of methods of renal replacement therapy for abolishment of hyperhydration in patients with decompensated chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Hemofi | 2010 |
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Diu | 2011 |
Phase III clinical pharmacology study of tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body | 2011 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arg | 2003 |
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; E | 2008 |
The effect of amiloride/hydrochlorothiazide combination vs furosemide plus potassium supplementation in the treatment of oedema of cardiac origin.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Edema, Car | 1981 |
Comparison of the chronic effects of bendrofluazide, bumetanide and frusemide on plasma biochemical variables.
Topics: Aged; Analysis of Variance; Bendroflumethiazide; Blood Chemical Analysis; Bumetanide; Clinical Trial | 1981 |
Bumetanide--acute and long term studies of a new high potency diuretic.
Topics: Aged; Bicarbonates; Bumetanide; Chlorides; Creatinine; Diuresis; Diuretics; Edema, Cardiac; Female; | 1975 |
[Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
Topics: Aged; Diuretics; Drug Combinations; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hydro | 1985 |
14 other studies available for furosemide and Cardiac Edema
Article | Year |
---|---|
The pathophysiology of acute heart failure: the key role of fluid accumulation.
Topics: Acute Disease; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Hemodynamics; Humans | 2008 |
Fluid removal: are we any wiser?
Topics: Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kidney Function Tests; Male; Risk Assessm | 2008 |
Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema.
Topics: Administration, Oral; Adult; Aged; Digitalis Glycosides; Diuretics; Edema, Cardiac; Furosemide; Hear | 1980 |
[Furosemide and metolazone: a highly effective diuretic combination].
Topics: Ascites; Body Weight; Diuresis; Diuretics; Drug Combinations; Edema, Cardiac; Female; Furosemide; He | 1980 |
Evaluation of diuretic therapy by impedance cardiography in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Cardiography, Impedance; Diuretics; Edema, Cardiac; Evaluation Studies a | 1980 |
Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance.
Topics: Adult; Blood Pressure; Cardiomyopathy, Dilated; Diastole; Diuretics; Dose-Response Relationship, Dru | 1997 |
[Basis and clinical aspects of diuretic drug therapy].
Topics: Acetazolamide; Benzothiadiazines; Diuretics; Edema; Edema, Cardiac; Furosemide; Glaucoma; Humans; Hy | 1979 |
Continuous infusion of frusemide in refractory oedema.
Topics: Aged; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Infusions, Parenteral; Length of St | 1978 |
[Furosemide in progressive doses. Its use in edematous states].
Topics: Diuresis; Drug Evaluation; Edema; Edema, Cardiac; Female; Furosemide; Humans; Liver Cirrhosis; Male; | 1978 |
Potassium supplements in patients receiving long-term diuretics for oedema.
Topics: Bendroflumethiazide; Body Composition; Bumetanide; Diuretics; Edema, Cardiac; Female; Furosemide; He | 1976 |
[Irrigation of edemas and thrombosis].
Topics: Ascites; Blood Viscosity; Diuretics; Edema, Cardiac; Furosemide; Hematocrit; Humans; Thrombosis | 1975 |
[Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Drug Therapy, Combination; Edema, Cardiac; Female; | 1991 |
[Indications for therapy with diuretics].
Topics: Aldosterone; Blood Volume; Cardiac Output; Diuretics; Edema; Edema, Cardiac; Furosemide; Humans; Kid | 1985 |
[My prescription of diuretics].
Topics: Adolescent; Aged; Ascites; Diuretics; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Kid | 1974 |